iKang Healthcare Group (NASDAQ:KANG) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Friday.

Separately, TheStreet raised shares of iKang Healthcare Group from a “d+” rating to a “c” rating in a research report on Friday, December 15th.

Shares of iKang Healthcare Group (NASDAQ:KANG) traded up $0.13 on Friday, reaching $15.82. 132,502 shares of the company traded hands, compared to its average volume of 223,285. The company has a market capitalization of $1,080.00, a price-to-earnings ratio of -105.47 and a beta of 0.30. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.78 and a current ratio of 0.80. iKang Healthcare Group has a 52-week low of $11.70 and a 52-week high of $18.41.

Hedge funds have recently made changes to their positions in the business. Fosun International Ltd grew its holdings in iKang Healthcare Group by 40.2% during the third quarter. Fosun International Ltd now owns 3,571,138 shares of the medical research company’s stock valued at $48,139,000 after purchasing an additional 1,023,199 shares during the last quarter. Pictet Asset Management Ltd. acquired a new position in iKang Healthcare Group during the third quarter valued at approximately $330,000. Maso Capital Partners Ltd grew its holdings in iKang Healthcare Group by 8.7% during the third quarter. Maso Capital Partners Ltd now owns 1,504,062 shares of the medical research company’s stock valued at $20,275,000 after purchasing an additional 120,655 shares during the last quarter. GLG Partners LP grew its holdings in iKang Healthcare Group by 15.5% during the second quarter. GLG Partners LP now owns 1,754,570 shares of the medical research company’s stock valued at $21,529,000 after purchasing an additional 235,056 shares during the last quarter. Finally, FIL Ltd grew its holdings in iKang Healthcare Group by 45.4% during the second quarter. FIL Ltd now owns 360,922 shares of the medical research company’s stock valued at $4,429,000 after purchasing an additional 112,615 shares during the last quarter. Institutional investors own 33.08% of the company’s stock.

TRADEMARK VIOLATION WARNING: “iKang Healthcare Group (KANG) Downgraded to Hold at BidaskClub” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2018/01/05/ikang-healthcare-group-kang-downgraded-to-hold-at-bidaskclub.html.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.